Jorge L. Del‐Aguila
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Washington University in St. Louis(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Bioinformatics and Genomic Networks, Neuroinflammation and Neurodegeneration Mechanisms, Genetic Associations and Epidemiology, Inflammation biomarkers and pathways
Most-Cited Works
- → ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy(2017)1,200 cited
- → A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease(2017)463 cited
- → An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations(2019)363 cited
- → Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status(2016)343 cited
- → The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk(2019)279 cited
- → Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers(2017)242 cited